p53 Exon 7 mutations as a predictor of poor prognosis in patients with colorectal cancer

Cancer Letters

Volumn 130, Issue 1-2, 1998, Pages 153-160

  Iniesta, Pilar ^a   Vega, Francisco J ^a   Caldés, Trinidad ^b   Massa, María José ^a   De Juan, Carmen ^a   Cerdán, Francisco J ^b   Sánchez, Andrés ^b   López, Jose A ^b   Torres, Antonio J ^b   Balibrea, José L ^b   Benito, Manuel ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Colorectal cancer; p53 exon 7 mutations; Prognosis

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; COLON CARCINOGENESIS; COLORECTAL CANCER; EXON; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

AGED; ANALYSIS OF VARIANCE; COLORECTAL NEOPLASMS; EXONS; FEMALE; GENES, P53; HUMANS; MALE; NEOPLASM STAGING; POINT MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS;

EID: 0032516684     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00138-4     Document Type: Article

References (33)

1. Parkin D.M., Pisani P., Ferlay J. Estimate of the world incidence of eighteen major cancers in 1985. Int. J. Cancer. 54:1993;594-606.
2. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.
3. Hamilton S.R. Molecular genetics of colorectal carcinoma. Cancer. 70:1992;1216-1221.
4. Smith M.L., Fornace A.J. Genomic instability and the role of p53 mutations in cancer cells. Curr. Opin. Oncol. 7:1995;69-75.
5. Greenblatt M.S., Benett W.P., Hollstein M., Harris C.C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54:1994;4855-4878.
6. Guillouf C., Rosselli F., Krishnaraju K., Moustacchi E., Hoffman B., Liebermann D.A. p53 involvement in control of G2 exit of the cell cycle: role in DNA damage-induced apoptosis. Oncogene. 10:1995;2263-2270.
7. Hollstein M., Sidransky D., Vogelstein B., Harris C.C. p53 mutations in human cancers. Science. 253:1991;49-53.
8. Goh H.S., Yao J., Smith D.R. p53 point mutation and survival in colorectal cancer patients. Cancer Res. 55:1995;5217-5221.
9. Hamelin R., Laurent P.P., Olschwang S., Jego N., Asselain B., Remvikos Y., Girodet J., Salmon R.J., Thomas G. Association of p53 mutations with short survival in colorectal cancer. Gastroenterology. 106:1994;42-48.
10. Shin D.M., Kim J., Ro J.Y., Hittelman J., Roth J.A., Hong W.K., Hittelman W.N. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res. 54:1994;321-326.
11. Vogelstein B., Kinzler K. p53 function and dysfunction. Cell. 70:1992;523-526.
12. Kemp C.J., Donehower L.A., Bradley A., Balmain A. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell. 74:1993;813-822.
13. Turnbull R.B., Watson F.R., Spratt J. Cancer of the colon: the influence of the no-touch isolation technique on survival rates. Ann. Surg. 166:1967;420-427.
14. B.C. Morson, L.H. Sobin, Histological typing of intestinal tumors, in: International Histological Classification of Tumors, WHO, Geneva, 1976, p. 15.
15. Blin N., Stafford D.W. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res. 3:1976;2303-2308.
16. Hsu S.M., Raine L., Fanger H. The use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase technique: a comparison between ABC unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29:1981;577-580.
17. Vega F.J., Iniesta P., Caldés T., Sánchez A., López J.A., de Juan C., Diaz-Rubio E., Torres A., Balibrea J.L., Benito M. p53 exon 5 mutations as prognostic indicator of shortened survival in non-small cell lung cancer. Br. J. Cancer. 76:1997;44-51.
18. Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
19. Potter J.D., Slattery M.L., Bostick R.M., Gapstur S.M. Colon cancer: a review of the epidemiology. Epidemiol. Rev. 15:1993;499-545.
20. Fredrikson M., Axelson O., Sun X.F., Arbman G., Nilsson E., Nordenskjold B., Sjodahl R., Soderkvist P. A pilot study on risk factors and p53 gene expression in colorectal cancer. Br. J. Cancer. 73:1996;1428-1430.
21. Lane D.P. p53, guardian of the genome. Nature. 358:1992;15-16.
22. Baker S.J., Preisinger A.C., Jessup J.M., Paraskeva C., Markowitz S., Willson J.K., Hamilton S., Vogelstein B. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res. 50:1990;7717-7722.
23. Bertorelle R., Esposito G., Del Mistro A., Belluco C., Nitti D., Lise M., Chieco-Bianchi L. Association of p53 gene and protein alterations with metastases in colorectal cancer. Am. J. Surg. Pathol. 19:1995;463-471.
24. Maruyama K., Tanak T., Baba S., Nakamura S., Endo Y., Sugimura H. p53 accumulation in colorectal cancer with hepatic metastasis. Jpn. J. Cancer Res. 87:1996;368-376.
25. Livingstone L.R., White A., Sprouse J., Livanos E., Jacks T., Tlsty T.D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell. 70:1992;923-935.
26. Yin Y., Tainski M.A., Bischoff F.Z., Strong L.C., Wahl G.M. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell. 70:1992;937-948.
27. Somers K.D., Merrick M.A., Lopez M.E., Incognito L.S., Schechter G.L., Casey G. Frequent p53 mutations in head and neck cancer. Cancer Res. 52:1992;5997-6000.
28. Kinzler K.W., Vogelstein B. Cancer therapy meets p53. N. Engl. J. Med. 331:1994;49-50.
29. Hamada M., Fujiwara T., Hizuta A., Gochi A., Naomoto Y., Takakura N., Takahashi K., Roth J.A., Tanaka N., Orita K. The p53 gene is a potent determinant of chemosensitivity and radiosensitivity in gastric and colorectal cancers. J. Cancer Res. Clin. Oncol. 122:1996;360-365.
30. Kern S.E., Fearon E.R., Tersmette K.W., Enterline J.P., Leppert M., Nakamura Y., White R., Vogelstein B., Hamilton S.R. Clinical and pathological associations with allelic loss in colorectal carcinoma. J. Am. Med. Assoc. 261:1989;3099-3103.
31. Laurent-Puig P., Olschwang S., Delattre O., Remvikos Y., Asselain B., Melot T., Validire P., Muleris M., Girodet J., Salmon R.J. Survival and acquired genetic alterations in colorectal cancer. Gastroenterology. 102:1992;1136-1141.
32. Milner J. Flexibility: the key to p53 function? Trends Biosci. 20:1995;49-51.
33. Cho Y., Gorina S., Jeffrey P.D., Pavletich N.P. Crystal structure of a p53 tumor-suppressor-DNA complex: understanding tumorigenic mutations. Science. 265:1994;346-355.